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Background: The study was conducted to demonstrate improved survival (30-day mortality) after the introduction of an
emergency endovascular therapy protocol for ruptured abdominal aortic aneurysms (rAAA). Numerous authors have
successfully demonstrated reduced mortality in patients with rAAA using endovascular techniques. Comparison of
endovascular aneurysm repair (EVAR) with open repair for rAAAmay be misleading, however, because EVAR cannot be
performed on all patients, and selection bias may explain the superior performance of any given surgical or endovascular
strategy. We developed a model to predict mortality in patients before the introduction of EVAR (preprotocol
population), applied this model to predict 30-day mortality among prospective patients (postprotocol population), and
compared observed vs expected results.
Methods: We assessed 126 patients with rAAA. Primary outcome was 30-day mortality. Potential confounding variables
were age, sex, presurgical lowest recorded systolic blood pressure (SBP), and glomerular filtration rate (GFR). A logistic
regression model incorporating significant confounders was used to evaluate changes in 30-day mortality for all patients
with rAAA after introduction of the EVAR protocol. Separate logistic regressions were done to compare 30-daymortality
for preprotocol vs patients receiving EVAR and preprotocol vs patients receiving postprotocol open repair. Cumulative
sum (CUSUM) analysis was used to assess shifts in the performance of the rAAA program over time.
Results: Significant confounders were SBP, absence of SBP, and GFR. Logistic regression found evidence of lower
mortality after the protocol was introduced, 17.9% vs 30.0% (odds ratio [OR], 0.385; 95% confidence interval [CI],
0.141 to 0.981; P  .046). Comparison of all open repairs (preprotocol and postprotocol) and EVAR demonstrated
decreased risk for EVAR of 5.0% vs 28.3% (OR, 0.109; 95%CI, 0.013 to 0.906; P .0084). Unstable patients (SBP<80)
showed a trend towards improved survival with EVAR relative to open repair (14.3% vs 56.0%, P  .061). Comparison
of preprotocol surgery with open repair after the introduction of the protocol found no evidence of a difference between
mortality rates for the open procedures—30.0% (preprotocol) vs 25.0% (postprotocol; OR, 0.688; 95% CI, 0.335 to
1.415, P  .3031)—demonstrating that the improved performance observed with CUSUM analysis was related to the
introduction of the EVAR protocol.
Conclusion: Our predictive model using “weighted” CUSUM analysis (a measure of performance over time) demon-
strated that a predefined strategy of management of rAAA that includes EVAR is associated with improved (P < .05)
mortality. Unstable patients with rAAA may be particularly benefited by EVAR and should not be excluded from repair.
Appropriate patients with rAAA who are undergoing treatment in experienced vascular centers should be offered EVAR
as the treatment of choice. ( J Vasc Surg 2007;45:443-50.)A meta-analysis published in 2002 of the last 50 years
demonstrated that open surgical repair of ruptured abdom-
inal aortic aneurysms (rAAA) continues to be associated
with surgical mortality rates of 45 to 50%1 and an overall
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doi:10.1016/j.jvs.2006.11.047mortality of 75% to 90%, including prehospital deaths,2
despite advances in aortic grafts and open surgical and
anesthetic technique. Since the advent in 1991 of mini-
mally invasive or endovascular aneurysm repair (EVAR) for
the treatment of elective, asymptomatic AAA, large pro-
spective registries and multicenter trials for EVAR have
demonstrated significant reductions in perioperative mor-
tality and in long-term aneurysm-related death.3-7 Mini-
mally invasive EVAR may particularly benefit high-risk
operative candidates, although this is still controversial.8
Our single institution experience includes treatment of
420 elective patients with AAA since May 1999 using
EVAR, with an overall 30-day mortality rate of 1.4% (6
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tality rate reported in other large series.3-6,9-10 The success-
ful treatment of these elective AAA patients has led to the
question of whether this technique may be extended to
patients requiring emergency repair of rAAA in an effort to
reduce the historically high mortality rates.
Since the Nottingham group11 reported the first case of
successful EVAR for rAAA in 1994, numerous authors have
demonstrated a strong correlation between the use of
EVAR for rAAA and improved 30-day mortality outcomes
compared with standard open repair.12,13 Most of these
authors have concluded that EVAR is a viable treatment
option in patients with appropriate anatomy. In 2005,
Alsac et al12 reported a review of the current literature
describing EVAR of rAAA, which demonstrated that
EVAR resulted in decreased procedure times, blood loss,
and length of stay, including intensive care unit stay. The
average postoperative mortality rate for this series was 24%
(range, 9% to 45%).13
We agree with other authors14 that an analysis restrict-
ing the comparison of EVAR with previous or concurrent
open procedures might be misleading owing to selection
bias, including differences in patient risk factors, character-
istics, or anatomy; for example, patients selected for EVAR
may be at lower risk (more stable) than those selected for
open repair, with technically easier anatomy to manage (eg,
longer aortic necks). In addition, not all patients are ana-
tomic candidates for EVAR. Rather than asking “Is EVAR
better than open repair for rAAA?” we thought it was more
appropriate to ask, “Can we improve the performance of
our rAAA program by incorporating EVAR into our pro-
tocol?” recognizing the inherent selection bias and the
inability to treat all patients with EVAR.
Our strategy was to develop a model that predicted
mortality in patients before the introduction of EVAR
(preprotocol population), to apply this model to predict
30-day mortality among prospective patients (postpro-
tocol population), and then compare observed vs ex-
pected results.
METHODS
Patients treated with a contained or free-ruptured in-
frarenal AAA at a single university tertiary care center
between March 10, 2001, and February 10, 2006, were
prospectively enrolled into this study. Approval for the
study was obtained from the Conjoint Health Research
Ethics Board at the University of Calgary. Data were cap-
tured in a custom-designed Vascular Surgery Database
(Access, Microsoft, Redmond, Wash). Charts were cross-
referenced to validate data. To ensure that only those
patients with documented blood outside of the aortic wall
were included in the study, we excluded 26 patients with a
coded diagnosis of rAAA and with symptoms of rAAA, but
with no blood outside the aortic sac.
Patients enrolled before January 2004 were treated
with standard open repair with a Dacron tube graft. After
January 2004, an algorithm for endovascular treatment of
rAAA was implemented (Fig 1). These patients underwenteligibility assessment for an intention-to-treat protocol us-
ing a Zenith (Cook Inc, Bloomington, Ind.) aortouniiliac
or aortobiiliac EVAR device.
We broadened the anatomic inclusion criteria (Table I)
compared with those recommended for elective EVAR.
Specifically, we included those patients with a shorter neck
length of 10mm in the expectation that proximal seal of the
graft from the aneurysm could be achieved using adjunctive
techniques (ie, Palmaz stent, Cordis, Miami Lakes, Fla) at
the discretion of the operating surgeon. We were willing to
accept a less favorable neck length to achieve control of
life-threatening hemorrhage as part of a damage control
concept. Those who did not meet the anatomic inclusion
criteria underwent a standard open repair.
Emergency ruptured abdominal aortic aneurysm
repair algorithm. The algorithm for emergency rAAA
repair was implemented in January 2004 (Fig 1). All pa-
tients with a diagnosis of a rAAA were first assessed clini-
cally by the attending surgeon. The treatment algorithm
Fig 1. Emergency ruptured abdominal aortic aneurysm (rAAA)
endovascular repair (EVAR) algorithm. *Permissive hypotension is
defined as state of consciousness with a systolic blood pressure80
mm Hg. Endovascular on call is defined as the availability of a
vascular surgeon with endovascular privileges. CTA, Computed
tomography angiography.
Table I. Criteria used to determine anatomic suitability
for emergency endovascular aneurysm repair
Anatomic inclusion criteria for emergency endovascular aneurysm
repair
1. Aortic neck 32 mm in diameter
2. Infrarenal neck 10 mm in length
3. Neck angulation 60°
4. Calcification 40%
5. Nonreverse funnel shaped neck
6. Iliac diameter 20 mm, 6 mm
7. Ability to preserve one internal iliacwas determined by whether EVAR was available and
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informed consent outlining the risks and benefits was ob-
tained. The two treatment paradigms were as follows:
I. Endovascular aneurysm repair available
Clinical assessment determined whether the patient
was hemodynamically stable or unstable, and thus assign-
ment into one of these two subgroups. Hemodynamic
stability was defined as a state of consciousness with a
systolic blood pressure 80 mm Hg.
A. Stable endovascular aneurysm repair group. Patients
who met the stability criteria were maintained in a state of
permissive hypotension with resuscitation to a blood pres-
sure of 90 mm Hg to maintain consciousness. These
patients underwent a spiral computed tomography (CT)
scan with intravenous contrast using 1.25-mm cuts. The
patients were then taken to the operating room (OR) for
EVAR performed under local, locoregional, or general
anesthetic, provided CT or intraoperative angiographic
anatomic inclusion criteria of the patient’s rAAA were met
(Table I). Groin cutdowns were performed to expose and
control the common femoral arteries.
Standard EVAR repair using conventional techniques
was performed, with the choice between aortouniiliac/
occluder/femoral crossover and aortobiiliac devices at the
discretion of the operating surgeon. An aortic occlusion
balloon (RELIANT, Medtronic, Minneapolis, Minn;
PVL6, Cook, Queensland Australia; or CODA, Cook,
Indianapolis, Ind) was placed above the level of the renal
arteries during manipulation of the endovascular device
only if signs of intraoperative hemodynamic instability de-
veloped, and was withdrawn immediately before to stent-
graft deployment.
B. Unstable endovascular aneurysm repair group. Pa-
tients who were deemed unstable were taken directly to the
OR from the emergency department. A groin cutdown was
performed under a local anesthetic to expose and control a
common femoral artery. An aortic occluding balloon was
then inserted above the renal arteries and inflated to create
a cross-clamp of the aorta, which allowed an angiogram to
be performed to assess anatomic suitability.
Standard EVAR repair with bilateral groin cutdowns
was then performed on patients who had amenable anat-
omy, with the choice between aortouniiliac/occluder/
femoral crossover and aortobiiliac devices at the discretion
of the operating surgeon. The aortic occlusion balloon was
deflated and withdrawn immediately before main body
stent graft deployment.
For patients in whom the aortic anatomy was not
amenable to EVAR, the intra-aortic occluding balloon was
left in place in the proximal aorta above the rAAA to arrest
ongoing bleeding. Once the patient had been appropriately
resuscitated, a general anesthetic was administered and a
standard open surgical cross-clamp placement and repair
was performed with a Dacron tube graft.II. Endovascular aneurysm repair not available
(open repair)
Patients were included in this group if the on-call
surgeon did not have EVAR privileges or if their workup in
the EVAR group showed they did not have anatomic
suitability for EVAR. The patient’s clinical hemodynamic
stability was ascertained as defined previously.
A. Stable open repair group. Patients who where stable
were maintained in a state of permissive hypotension and
underwent a spiral CT scan to confirm the diagnosis and
assist with preoperative planning before they were taken
to the OR for a standard open rAAA repair with a Dacron
tube graft under a general anesthetic. Whenever possible,
an intra-aortic occluding balloon was placed through a
common femoral artery cutdown to arrest ongoing bleed-
ing before administration of the general anesthetic and
laparotomy.
B. Unstable open repair group. Patients who were un-
stable were taken directly to the OR from the emergency
department and underwent open rAAA repair without
prior imaging. Whenever possible, an intra-aortic occlud-
ing balloon was placed through a common femoral artery
cutdown to arrest ongoing bleeding before administration
of the general anesthetic and laparotomy.
Statistical methods. The primary outcome was 30-
day all-cause mortality. Potential confounding variables
were age, gender, presurgical lowest SBP, and glomerular
filtration rate (GFR). The GFR (mL/[min · 1.73m2]) was
calculated on the basis of serum creatinine level (mol/L),
age, sex, and race using the Modification of Diet in Renal
Disease Study Group formula.15 For four patients with
missing creatinine values, the missing value was conserva-
tively calculated as the mean serum creatinine value for
pre-EVAR patients (95.73 mol/L) before the calculation
of GFR.
If continuous variables were normally distributed, we
used t tests to compare the means of these variables of the
patients treated before and after the introduction of the
protocol, otherwise Wilcoxon tests were used. The Fisher
exact test was used to compare binary variables. A two-
sample test of proportion was done to compare mortality of
Table II. Coefficients in the risk-adjustment model
based on pre-endovascular aneurysm repair patients*
Coefficient SE Z P
(Intercept) 4.9287 1.6696 2.95 .0032
GFR 0.0311 0.0130 2.40 .0164
SBP 0.0369 0.0133 2.78 .0054
Absence of SBP 2.7209 1.4570 1.87 .0618
SE, Standard error; GFR, glomerular filtration rate; SBP, systolic blood
pressure.
*The C statistic for this model was 0.82. The predicted log (odds) of
mortality for patients with a systolic blood pressure (SBP) at the time of
surgery is  (4.93 0.0311) (GFR 0.0369) SBP. For patients with
no SBP at the time of surgery the formula is   (2.21  0.0311) GFR.open and EVAR patients who were unstable. After review-
press
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sence of SBP, and GFR were determined to significantly
predict 30-day mortality. These variables were used to
derive a logistic regression model to evaluate changes in the
30-day mortality postprotocol (Table II).
We used a logistic regression model including the sig-
nificant variables identified in the preprotocol data (SBP,
absence of SBP, and GFR) to evaluate changes in 30-day
mortality after the introduction of the EVAR protocol.
This model included patients before the introduction of the
protocol as well as all patients receiving open or EVAR
procedures after the introduction of the protocol. We also
used separate logistic regression models to compare pre-
EVAR 30-day mortality with 30-day mortality for all pa-
tients receiving EVAR procedures and patients receiving
open procedures after the introduction of the protocol.
We used risk-adjusted cumulative sum (CUSUM) plots
to examine shifts in 30-day mortality after the introduction
of the EVAR protocol. Risk-adjusted CUSUM plots are
highly sensitive to shifts in surgical performance.16-26
These plots use two CUSUM lines. The upper line detects
poorer-than-expected performance over time and is con-
strained so that it cannot go below zero. A horizontal
“alert” line is crossed if outcome performance was worse
than expected according to the risk-adjustment model. For
surgeons operating at the level of pre-EVAR performance,
this line would be crossed every 100 surgeries (ie, the
horizontal alert line corresponds to an average run length
of 100). The lower line detects better-than-expected per-
formance and is constrained so that it cannot go above
zero. A horizontal “superior” line is crossed if outcome
performance is better than expected according to the risk-
adjustment model. This line would be crossed every 100
surgeries by surgeons operating at the level of pre-EVAR
protocol surgeons. The constraints on the lines (upper line
constrained to be above zero and the lower line constrained
to be below zero) ensure that the CUSUM lines will be
sensitive to clusters of bad or good events.
The risk-adjustment model for the CUSUM lines was
developed using SBP, absence of SBP, and GFR to predict
the 30-day mortality for patients before the introduction of
Table III. Preoperative clinical characteristics of patients b
Variable Preprotocol mean (% total) Po
Age 71.01 (8.14)
Female (n) 11 (15.7)
Hgb 109.69 (30.85)
WBC 13.86 (12.64)
Sodium 137.30 (16.85)
Potassium 4.16 (0.72)
GFR 83.07 (36.35)
SBP 92.51 (45.80)
SBP 80 (n) 25 (35.7)
No BP (n) 8 (11.4)
WBC, White blood cell; GFR, glomerular filtration rate; SBP, systolic blood
*Fisher’s exact test.the protocol (Table II). This model was then used topredict the probability of death for each patient according
to the covariate values. The outcome for each patient (lived
or died) and the predicted probability of death determined
the amount of upward or downward movement in the
CUSUM lines. Data points were therefore “weighted,” in
that mortality in patients with a low probability of death
produced greater negative impact than did mortality in
patients with a high probability of death. Conversely, sur-
vival in patients with a high predicted mortality had greater
positive impact than did survival in patients with a low
predicted mortality. This helped to eliminate “survivor
bias,” whereby low-risk patients artificially improved
outcomes.
RESULTS
Clinical characteristics of patients before and after
the introduction of the EVAR protocol are presented in
Table III. EVAR was done in 20 (36%) of the 56 patients in
the postprotocol period. Procedures were completed in the
OR with portable fluoroscopic support. Two patients had
local anesthesia, and the others had general anesthesia.
Twelve patients had aortobiiliac/occluder/femoral-femoral
bypass procedures, six patients had aortobiiliac procedures,
and two patients with ruptured saccular aneurysms had
tube endograft repair. Postprotocol patients were found to
have decreased renal function as indicated by lower presur-
gical GFR (t124 2.967, P .0036). Without adjustment
for clinical characteristics, there was no evidence of lower
mortality for all patients (combined open and EVAR pro-
cedures) after the introduction of the EVAR protocol (P
.146, Fisher exact test).
Logistic regression: (risk-adjusted outcomes). The
results of risk-adjusted logistic regression are presented in
Table IV. After adjusting for SBP, absence of SBP, and
GFR, there was evidence of a lower mortality rate after the
introduction of the protocol: 21 (30.0%) of 70 vs 10
(17.9%) of 56 (OR, 0.385; 95% CI, 0.141 to 0.981; P 
.046). A similar comparison of all open surgeries (prepro-
tocol and postprotocol) and EVAR procedures demon-
strated evidence of decreased risk for EVAR procedures:
28.3% vs 5.0% (OR, 0.109; 95% CI, 0.013 to 0.906; P 
e and after introduction of the endovascular protocol
ocol mean (% total) Test statistic P
2.66 (7.91) t124  1.14 .2554
13 (23.2) .3624*
1.66 (23.33) t122  0.39 .6944
1.65 (4.63) .9606*
9.79 (4.98) .3218*
4.16 (0.71) t121  0.01 .9919
5.39 (28.86) t124  2.97 .0036
4.07 (44.68) t124  0.19 .8483
20 (35.7) 1.0000*
6 (10.7) 1.0000*
ure.efor
stprot
7
11
1
13
6
9.0084), and a logistic regression comparing preprotocol
e, no
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duction of the protocol found no evidence of a difference
between mortality rates for the open procedures: 30.0%
vs 25.0% (OR, 0.688; 95% CI, 0.335 to 1.415; P 
.3031).
Unstable patients (systolic blood pressure<80 mm
Hg). No difference was evident between groups with re-
spect to unstable patients between preprotocol (25/70
[35.7%]) and postprotocol (20/56 [35.7%]; P  1, two-
sample test of proportion), or between all preprotocol and
postprotocol open (38/106 [35.9%]) and EVAR patients
(7/20 [35%]; P  1).
Themortality was 20 (53%) of 38 among unstable open
patients, 14 (56%) of 25 among pre-EVAR protocol pa-
tients, and one (14.3%) of seven among unstable EVAR
patients. There was a trend towards improved survival in
unstable rAAA patients with EVAR compared with open
repair, although not statistically significant (P .0617, test
of proportion).
Cumulative sum plots. The coefficients for the risk-
adjustment model based on the pre-EVAR protocol pa-
tients are presented in Table II. The C statistic for this
Fig 2. Cumulative sum (CUSUM) plot for all repairs. Vertical
dashed line indicates the introduction of the ruptured abdominal
aortic aneurysm endovascular aneurysm repair (EVAR) protocol.
After the introduction of the protocol, the lower CUSUM line
crosses the “superior” line within 35 surgeries (P  .059).
Table IV. Comparison of mortality with odds ratios after
Cohort Mortality % Cohort
Preprotocol (All) 21/70 (30) Postprotocol (All)
All open 30/106 (28) EVAR
Preprotocol open 21/70 (30) Postprotocol Open
CI, Confidence interval; EVAR, endovascular aneurysm repair.
*Odds ratio from logistic regression that adjusted for systolic blood pressurmodel was 0.82. Fig 2 presents a CUSUM plot showing theshift in performance for all patients pre-EVAR and post-
EVAR protocol. The lower CUSUM line crosses the “su-
perior” line in the first 35 repairs after the introduction of
the protocol. The CUSUM line for surgeons with a pre-
EVAR level of performance would, on average, cross this
line every 100 surgeries. The probability that pre-EVAR
surgeries would cross this line within 35 surgeries is
0.059. CUSUM plots showing shifts in performance
associated with open and closed procedures are pre-
sented in Fig 3. EVAR surgical performance improved
during the study, whereas open surgical performance
Fig 3. Cumulative sum (CUSUM) plots for (A) endovascular
aneurysm repair and (B) open repairs after the introduction of the
EVAR protocol. Note the stable performance of open repairs, with
a trend towards improvement in the performance of endovascular
repairs.
sting for patient risk factors
Mortality % OR* CI P
10/56 (18) 0.385 0.141-0.981 .046
1/20 (5) 0.109 0.013-0.906 .0084
9/36 (25) 0.688 0.335-1.415 .3031
blood pressure, and glomerular filtration rate.adjuremained relatively stable.
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The incidence of rAAA continues to increase despite a
100% increase in elective repairs during the past 20 years,
the development of screening programs, and overall im-
provements in public and physician awareness of the pa-
thology.27 EVAR repair for rAAA, with a reduced physio-
logic insult,13,28-30 offers a less invasive procedure for these
often moribund patients and has been successfully applied
in this emergency setting.31 The current use of EVAR for
rAAA is still low, however, accounting for only 6% of repairs
for rAAA in a study involving nearly 30% of the United
States population.32 Interpretation of results for “like pa-
tients” has been limited by selection bias and the anatomic
restrictions of endovascular technology.
Similar to other investigators, we have demonstrated an
improved survival (5.0% mortality) in both stable and un-
stable patients undergoing EVAR for rAAA compared with
those undergoing open repair (28.3%mortality). However,
the primary objective of the study was to determine if a new
protocol incorporating endovascular technology for ana-
tomically suitable patients would significantly improve the
odds of patients surviving their illness at presentation. As a
result of the implementation of our intent-to-treat EVAR
protocol, we report an improved performance of our rAAA
program with respect to 30-day mortality (30.0% vs 17.9%)
for all patients presenting with rAAA.
Other investigators have also demonstrated the utility
of the development of a protocol-based approach to EVAR
for rAAA. Arya et al33 demonstrated a reduced mortality
(39% vs 59%) for rAAA after introduction of an intent-to-
treat EVAR protocol. Mehta et al34 reported an 18% mor-
tality for rAAA patients treated with EVAR alone. A suba-
nalysis of their overall results demonstrated a combined
postprotocol rAAA mortality for open surgical and EVAR
repair of 35%. Our 17.9% mortality rate postprotocol and
our 5.0% EVAR mortality rate for rAAA is lower than that
reported in this and other series,14 as is our 30% mortality
rate for index open aortic repair. Single institution reports
of mortality post EVAR for rAAA are 8% to 14%.13,31,35,36
A recent systematic review and meta-analysis of EVAR
observational studies for rAAA involving 400 patients dem-
onstrated a pooled 30-day mortality rate of 20%.37
Typical reported mortality rates for open repair are 32%
to 50%.1,2,14 Our center receives referrals from a large
geographic area and represents the only tertiary care center
for vascular repair for a catchment population of 2 mil-
lion. The patients that arrived to undergo repair at our
center were sick: 35% patients were unstable (SBP80mm
Hg), and 11% of these had no recordable blood pressure.
Those patients receiving EVAR repair had a comparable
SBP to those receiving open repair (101.2 vs 93.32 mm
Hg, respectively; P  .476, t test). A subgroup analysis
demonstrated no difference in the proportion of unstable
patients in either the preprotocol vs postprotocol, or open
vs EVAR groups.
Unlike other series of EVAR for rAAA,38 we did not
use hemodynamic instability to exclude patients. However,that these patients survived prolonged transport to present
alive in the emergency department for surgical repair sug-
gests that they were physiologically more robust. The re-
sultant self-selection of our population may therefore limit
the applicability of our results to centers with decreased
transport time and distances, as 28 (26%) of our patients for
whom data were available were transferred from “out of
province” or “out of city.”
Nevertheless, the lower preprotocol mortality rate also
effectively raised the bar in terms of our group having to
demonstrate the significant improvements observed in the
postprotocol cohort. The low postprotocol and EVAR
mortality rates in our series may also reflect the experience
of our endovascular team and our large inventory of readily
available commercial devices. In addition, we preferentially
used the aortouniiliac device for unstable patients, which is
more rapidly placed and thus shortens the time to endoseal
owing to the elimination of the need to cannulate the
contralateral limb. The benefits of the aortouniiliac system
for rAAA have been noted by other investigators.14,39 It has
also been our observation that the routine use of early
balloon control of the aorta, even with open surgical cases,
reduces the incidence of prolonged shock and hemody-
namic instability.
We use the term endovascular spillover to describe the
application of endovascular techniques to improve the per-
formance of open techniques. Our use of these balloon
techniques to control the aorta during open repair ante-
dated our protocol and also contributed to reduced base-
line and postprotocol mortality. And finally, the elimina-
tion of routine preoperative CT scanning (and the
associated delay to OR) may have benefited our patient
population postprotocol and reduced the selection bias
observed in other studies,13,31,40 whereby patients se-
lected for EVAR had to be stable enough to undergo CT
scanning.
The primary limitation of our study is its lack of true
randomization. We expect a major impediment to random-
ization in future studies will be an exceptionally high rate of
treatment arm crossover owing to the strict anatomic lim-
itations imposed by current endovascular technology and
the current limited availability of skilled endovascular teams
comfortable with emergency EVAR for rAAA. Our liberal
application of anatomic inclusion criteria (eg, neck length
of 10 cm) and our lack of medical exclusion criteria allowed
for EVAR repair in 36% of our postprotocol cohort, which
is similar to the 23% to 50% EVAR rates for rAAA reported
by experienced centers.14,36,41-46
Our bias is that medical exclusion of EVAR for patients
with rAAA is inappropriate and that the greatest benefits of
this technology will be observed in the sickest of the pa-
tients. Although not statistically significant, likely because
of the small numbers in our series, we did see a trend (P 
.06) towards improved survival with EVAR in those pa-
tients with either no recordable SBP at presentation or with
SBP 80 mm Hg.
Recognizing that long-term durability of an aneurysm
repair may be as important as short-term outcome, we
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is an appropriate goal in treating a rAAA and that this
should increase the applicability of this technology. In this
setting, EVAR may also serve as a bridge to definitive
surgical or secondary EVAR interventions performed under
elective circumstances. Early in our series, only one surgeon
was performing EVAR for rAAA. With experience, all
members of the surgical group became involved, and ex-
clusion of EVAR for rAAA because of lack of availability
disappeared. We believe, therefore, that our nonrandom-
ized experience most closely approximates the realities
faced by of most endovascular centers worldwide.
Patient risk model. Our initial strategy was to rely on
the established predictive criteria for mortality in vascular
patients using the Portsmouth modification of the Physio-
logical and Operative Severity Score for Enumeration of
Mortality and Morbidity (P-POSSUM) methodology to
develop a risk-adjustment model for our postprotocol co-
hort.47 This mortality model includes variables for age,
blood urea nitrogen, sodium, potassium, hemoglobin, and
white cell count and has been shown to be highly predictive
of mortality in a United Kingdom rAAA patient popula-
tion. The ability of this model to predict mortality in our
preprotocol patients was suboptimal, however, with a C
statistic of only 0.66 (completely random would be 0.50).
This was likely due to the lack of available blood urea
nitrogen data in our patients because this was rarely ob-
tained preoperatively.
Further analysis was performed on additional patient
variables to validate a risk-adjustmentmodel specific for our
patient population that had better discrimination in pre-
dicting 30-day mortality (C statistic  0.82). The strong
association between GFR, SBP, and death observed in our
preprotocol cohort has been described by other investiga-
tors48 and allowed for the application of our predictive
model to our postprotocol group to assess risk-adjusted
performance.
The use of CUSUM analysis to assess performance has
been validated in multiple series looking at surgical perfor-
mance, learning curves, and endovascular learning curves,
in particular.39 The most important feature of our risk-
adjusted CUSUM analysis of mortality after treatment for
rAAA is the ability to determine a weighted impact to
stratify the patients according to their predicted risk of
death. This is a unique feature of our trial and, to our
knowledge, has not been previously reported. This feature
eliminated the bias observed in other studies whereby all
deaths and all survivals are equivalent, without any estima-
tion of the predicted risk of death for any particular patient.
This is particularly important during the assessment of
endovascular technology, where selection bias or anatomic
restrictions may limit application.
CONCLUSION
Our predictive model using weighted CUSUM analy-
sis, which is a measure of performance over time, demon-
strated that a predefined strategy of management of rAAA
that includes EVAR is associated with improved (P  .05)mortality. EVAR may be of particular benefit to unstable
patients with rAAA, and they should not be excluded from
repair. Appropriate patients with rAAA who are undergo-
ing treatment in experienced vascular centers should be
offered EVAR as the treatment of choice.
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